The genomic landscape of retinoblastoma: A review

Brigitte L. Thériault, Helen Dimaras, Brenda L. Gallie, Timothy Corson

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Retinoblastoma is a paediatric ocular tumour that continues to reveal much about the genetic basis of cancer development. Study of genomic aberrations in retinoblastoma tumours has exposed important mechanisms of cancer development and identified oncogenes and tumour suppressors that offer potential points of therapeutic intervention. The recent development of next-generation genomic technologies has allowed further refinement of the genomic landscape of retinoblastoma at high resolution. In a relatively short period of time, a wealth of genetic and epigenetic data has emerged on a small number of tumour samples. These data highlight the inherent molecular complexity of this cancer despite the fact that most retinoblastomas are initiated by the inactivation of a single tumour suppressor gene. This review outlines the current understanding of the genomic, genetic and epigenetic changes in retinoblastoma, highlighting recent genome-wide analyses that have identified exciting candidate genes worthy of further validation as potential prognostic and therapeutic targets. copy; 2013 Royal Australian and New Zealand College of Ophthalmologists.

Original languageEnglish
Pages (from-to)33-52
Number of pages20
JournalClinical and Experimental Ophthalmology
Volume42
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Retinoblastoma
Neoplasms
Epigenomics
Tumor Suppressor Genes
Oncogenes
Genome
Pediatrics
Technology
Therapeutics
Genes

Keywords

  • Cytogenetics
  • Epigenetics
  • MicroRNA
  • Retinoblastoma
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The genomic landscape of retinoblastoma : A review. / Thériault, Brigitte L.; Dimaras, Helen; Gallie, Brenda L.; Corson, Timothy.

In: Clinical and Experimental Ophthalmology, Vol. 42, No. 1, 01.2014, p. 33-52.

Research output: Contribution to journalArticle

Thériault, Brigitte L. ; Dimaras, Helen ; Gallie, Brenda L. ; Corson, Timothy. / The genomic landscape of retinoblastoma : A review. In: Clinical and Experimental Ophthalmology. 2014 ; Vol. 42, No. 1. pp. 33-52.
@article{29165090d75a4259afc84aec8a6c0177,
title = "The genomic landscape of retinoblastoma: A review",
abstract = "Retinoblastoma is a paediatric ocular tumour that continues to reveal much about the genetic basis of cancer development. Study of genomic aberrations in retinoblastoma tumours has exposed important mechanisms of cancer development and identified oncogenes and tumour suppressors that offer potential points of therapeutic intervention. The recent development of next-generation genomic technologies has allowed further refinement of the genomic landscape of retinoblastoma at high resolution. In a relatively short period of time, a wealth of genetic and epigenetic data has emerged on a small number of tumour samples. These data highlight the inherent molecular complexity of this cancer despite the fact that most retinoblastomas are initiated by the inactivation of a single tumour suppressor gene. This review outlines the current understanding of the genomic, genetic and epigenetic changes in retinoblastoma, highlighting recent genome-wide analyses that have identified exciting candidate genes worthy of further validation as potential prognostic and therapeutic targets. copy; 2013 Royal Australian and New Zealand College of Ophthalmologists.",
keywords = "Cytogenetics, Epigenetics, MicroRNA, Retinoblastoma, Single nucleotide polymorphism",
author = "Th{\'e}riault, {Brigitte L.} and Helen Dimaras and Gallie, {Brenda L.} and Timothy Corson",
year = "2014",
month = "1",
doi = "10.1111/ceo.12132",
language = "English",
volume = "42",
pages = "33--52",
journal = "Clinical and Experimental Ophthalmology",
issn = "1442-6404",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The genomic landscape of retinoblastoma

T2 - A review

AU - Thériault, Brigitte L.

AU - Dimaras, Helen

AU - Gallie, Brenda L.

AU - Corson, Timothy

PY - 2014/1

Y1 - 2014/1

N2 - Retinoblastoma is a paediatric ocular tumour that continues to reveal much about the genetic basis of cancer development. Study of genomic aberrations in retinoblastoma tumours has exposed important mechanisms of cancer development and identified oncogenes and tumour suppressors that offer potential points of therapeutic intervention. The recent development of next-generation genomic technologies has allowed further refinement of the genomic landscape of retinoblastoma at high resolution. In a relatively short period of time, a wealth of genetic and epigenetic data has emerged on a small number of tumour samples. These data highlight the inherent molecular complexity of this cancer despite the fact that most retinoblastomas are initiated by the inactivation of a single tumour suppressor gene. This review outlines the current understanding of the genomic, genetic and epigenetic changes in retinoblastoma, highlighting recent genome-wide analyses that have identified exciting candidate genes worthy of further validation as potential prognostic and therapeutic targets. copy; 2013 Royal Australian and New Zealand College of Ophthalmologists.

AB - Retinoblastoma is a paediatric ocular tumour that continues to reveal much about the genetic basis of cancer development. Study of genomic aberrations in retinoblastoma tumours has exposed important mechanisms of cancer development and identified oncogenes and tumour suppressors that offer potential points of therapeutic intervention. The recent development of next-generation genomic technologies has allowed further refinement of the genomic landscape of retinoblastoma at high resolution. In a relatively short period of time, a wealth of genetic and epigenetic data has emerged on a small number of tumour samples. These data highlight the inherent molecular complexity of this cancer despite the fact that most retinoblastomas are initiated by the inactivation of a single tumour suppressor gene. This review outlines the current understanding of the genomic, genetic and epigenetic changes in retinoblastoma, highlighting recent genome-wide analyses that have identified exciting candidate genes worthy of further validation as potential prognostic and therapeutic targets. copy; 2013 Royal Australian and New Zealand College of Ophthalmologists.

KW - Cytogenetics

KW - Epigenetics

KW - MicroRNA

KW - Retinoblastoma

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=84892552108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892552108&partnerID=8YFLogxK

U2 - 10.1111/ceo.12132

DO - 10.1111/ceo.12132

M3 - Article

C2 - 24433356

AN - SCOPUS:84892552108

VL - 42

SP - 33

EP - 52

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

SN - 1442-6404

IS - 1

ER -